It is unclear whether EGFR amplification is a feature of adenocarcinomas and adenosquamous carcinomas, which comprise 10–25% of cervical cancers (Smith et al, 2000; Chan et al, 2003; Arias-Pulido et al, 2008). The gene discussed is EGFR; the disease is adenosquamous carcinoma.